Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor
2021 ◽
Vol Volume 13
◽
pp. 169-180
2013 ◽
Vol 33
◽
pp. e302-e306
◽
2000 ◽
Vol 111
(1)
◽
pp. 381-381
◽
2020 ◽
Keyword(s):
2017 ◽
Vol 4
(10)
◽